Avanafil for the treatment of erectile dysfunction. An updated review

Avanafil is a highly selective phosfosdiesterase 5 inhibitor (PDE5 inhibitor), with rapid onset of action, approved by the Food and Drug Administration (FDA) and the European Medicines Agency for the treatment of erectile dysfunction (ED). It had been recently commercialized in Spain. This article p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archivos españoles de urología 2014-12, Vol.67 (10), p.839-847
Hauptverfasser:	Egui-Rojo, María Alejandra, Moncada-Iribarren, Ignacio, Carballido-Rodríguez, Joaquín, Martínez-Salamanca, Juan Ignacio
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Adult Erectile Dysfunction - drug therapy Humans Male Phosphodiesterase 5 Inhibitors - therapeutic use Pyrimidines - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!